TEST CATALOG ORDERING & RESULTS SPECIMEN HANDLING CUSTOMER SERVICE EDUCATION & INSIGHTS
Test Catalog

Test ID: PSAFT    
Prostate-Specific Antigen (PSA), Total and Free, Serum

Useful For Suggests clinical disorders or settings where the test may be helpful

Assessing the risk of prostate cancer in patients with borderline or moderately increased total PSA (4.0-10.0 ng/mL)

 

Determining which patients should have follow-up prostate biopsy

Highlights

In individuals with a total PSA between 4.0 and 10.0 ng/mL, free:total PSA ratio could help determine the relative risk of prostate cancer. The lower the free:total PSA ratio, the higher the risk of prostate cancer.

Method Name A short description of the method used to perform the test

Electrochemiluminescent Immunoassay (ECLIA)

NY State Available Indicates the status of NY State approval and if the test is orderable for NY State clients.

Yes

Reporting Name Lists a shorter or abbreviated version of the Published Name for a test

PSA Total and Free, S

Aliases Lists additional common names for a test, as an aid in searching

Free PSA
PSA (Prostate-Specific Antigen)
PSA Free/Total Ratio
PSA Total and Free
PSA Ratio